Clipping Board » Medical Affairs and Administration ─ Medical system, pharmaceuticals, and medical community-related reports
2010-01-12 (Strasbourg, France) – Is the A(H1N1) influenza pandemic the biggest medical scandal of the century?
While governments worldwide are spending vast sums to prevent the spread of the A(H1N1) flu and debates over the safety of flu vaccines rage on, an EU health official has exposed that the global outbreak of the A(H1N1) flu may be a fabricated illusion by pharmaceutical companies seeking massive profits—aimed at creating panic so they could rake in huge profits. Wolfgang Wodarg, head of the health committee at the Council of Europe in Strasbourg, France, recently described the A(H1N1) flu outbreak as "the biggest medical scandal of the century" in an interview with *The Progress Review*.
Wodarg harshly criticized several flu drug and vaccine manufacturers for exaggerating the severity of the A(H1N1) flu and using their influence to pressure the World Health Organization (WHO) into declaring a "pandemic" in June 2009.
**Criticism of Ineffective Vaccines**
Subsequently, countries scrambled to use their limited medical resources to purchase drugs and ineffective vaccines, allowing pharmaceutical companies to reap billions of pounds in profits. Wodarg, a German parliamentarian and infectious disease expert, has been closely monitoring the A(H1N1) flu issue since June 11, 2009.
He said, "What we are seeing is a mild flu and a false pandemic. Governments have wasted limited health budgets on combating a not-so-lethal disease."
"Millions of healthy people were needlessly injected with vaccines that were inadequately tested and whose side effects remain unknown." Wodarg also criticized the vaccines for being ineffective, pointing out that millions of healthy individuals were unnecessarily vaccinated with insufficiently tested drugs of uncertain side effects.
**Pharmaceutical Companies Sowed 'Seeds of Panic' Five Years Ago**
Wodarg further revealed that pharmaceutical companies had planted the "seeds of panic" as early as five years ago.
He noted that the avian flu in 2004 was more dangerous than the A(H1N1) flu but less contagious. However, the avian flu caused widespread panic in many countries, with fears that the virus could mutate to spread among humans. As a result, governments stockpiled large quantities of the antiviral drug Tamiflu and signed contracts with manufacturers to purchase millions of doses of vaccines, ensuring massive profits for pharmaceutical companies while eliminating any financial risks.
"The manufacturers were biding their time, waiting for the WHO to declare a pandemic so they could activate their contracts," he said. He explained that, logically, new flu strains emerge every year, and vaccines are updated accordingly. If existing vaccines had been adapted for the A(H1N1) flu, there would have been no need to declare a public health emergency.
**Pharmaceutical Companies Placed 'Insiders' in the WHO to Promote Vaccines**
Wodarg also discovered that major pharmaceutical companies, in order to promote their patented flu drugs and vaccines, had placed "insiders" within the WHO and other influential organizations. These individuals ultimately used their influence to lower the threshold for the WHO's definition of a "pandemic."
In 2009, the WHO revised its definition of a pandemic: as of June 2009, "a pandemic does not necessarily mean large numbers of infections or deaths." In other words, a virus that crosses borders and for which people have no immunity is now classified as a pandemic.
In June 2009, the WHO raised the A(H1N1) flu alert to the highest level, Phase 6, marking the first global flu pandemic declaration in 41 years.
**Investigating Key Figures Behind the Pandemic**
Following Wodarg's proposal, the Council of Europe earlier passed a resolution to investigate the role of pharmaceutical companies in the A(H1N1) flu outbreak.
Later in January, the Council of Europe will convene an emergency meeting to discuss the matter, after which strict investigations and hearings will be conducted into those responsible for declaring the public health emergency.According to Dutch media reports, Professor Osterhaus of Erasmus University in Rotterdam, nicknamed "Dr. Flu," is also a central figure in the global H1N1 flu panic.
The report states that Osterhaus is not only a key figure in the network referred to as the "pharmaceutical mafia" but also the chief advisor on pandemic flu for the World Health Organization. He has extremely close personal ties to the H1N1 vaccine production system and has profited from the billions of euros in vaccine sales.
The Dutch Senate has launched an investigation into Osterhaus, scrutinizing his serious breaches of public interest and misuse of funds.
Additionally, the UK’s *Daily Mail* previously exposed that Sir Anderson, who served as the British government’s advisor on the new flu, was employed by GlaxoSmithKline (GSK) with an annual salary of £116,000. The pharmaceutical company, which produces both antiviral drugs and flu vaccines, was one of the biggest beneficiaries of the H1N1 outbreak.
**2.6 deaths per 10,000 patients**
The mortality rate of the Spanish flu was 2 deaths per 100 patients, while the Asian flu and Hong Kong flu had 2 to 3 deaths per 1,000 patients. In contrast, the mortality rate of H1N1 flu was 2.6 deaths per 10,000 patients.
With a global population of 6 billion, previous flu outbreaks typically saw only 500 million people vaccinated. However, this time, the WHO estimated that around 3 billion vaccinations would be necessary, leading to an obvious surplus of vaccines.
Source: http://www. sinchew. com. my/ node/ 145681
France-EU: Drug Firms Inflated Pandemic for Profit - H1N1 Scandal of the Century?
While governments worldwide are spending vast sums to prevent the spread of the A(H1N1) flu and debates over the safety of flu vaccines rage on, an EU health official has exposed that the global outbreak of the A(H1N1) flu may be a fabricated illusion by pharmaceutical companies seeking massive profits—aimed at creating panic so they could rake in huge profits. Wolfgang Wodarg, head of the health committee at the Council of Europe in Strasbourg, France, recently described the A(H1N1) flu outbreak as "the biggest medical scandal of the century" in an interview with *The Progress Review*.
Wodarg harshly criticized several flu drug and vaccine manufacturers for exaggerating the severity of the A(H1N1) flu and using their influence to pressure the World Health Organization (WHO) into declaring a "pandemic" in June 2009.
**Criticism of Ineffective Vaccines**
Subsequently, countries scrambled to use their limited medical resources to purchase drugs and ineffective vaccines, allowing pharmaceutical companies to reap billions of pounds in profits. Wodarg, a German parliamentarian and infectious disease expert, has been closely monitoring the A(H1N1) flu issue since June 11, 2009.
He said, "What we are seeing is a mild flu and a false pandemic. Governments have wasted limited health budgets on combating a not-so-lethal disease."
"Millions of healthy people were needlessly injected with vaccines that were inadequately tested and whose side effects remain unknown." Wodarg also criticized the vaccines for being ineffective, pointing out that millions of healthy individuals were unnecessarily vaccinated with insufficiently tested drugs of uncertain side effects.
**Pharmaceutical Companies Sowed 'Seeds of Panic' Five Years Ago**
Wodarg further revealed that pharmaceutical companies had planted the "seeds of panic" as early as five years ago.
He noted that the avian flu in 2004 was more dangerous than the A(H1N1) flu but less contagious. However, the avian flu caused widespread panic in many countries, with fears that the virus could mutate to spread among humans. As a result, governments stockpiled large quantities of the antiviral drug Tamiflu and signed contracts with manufacturers to purchase millions of doses of vaccines, ensuring massive profits for pharmaceutical companies while eliminating any financial risks.
"The manufacturers were biding their time, waiting for the WHO to declare a pandemic so they could activate their contracts," he said. He explained that, logically, new flu strains emerge every year, and vaccines are updated accordingly. If existing vaccines had been adapted for the A(H1N1) flu, there would have been no need to declare a public health emergency.
**Pharmaceutical Companies Placed 'Insiders' in the WHO to Promote Vaccines**
Wodarg also discovered that major pharmaceutical companies, in order to promote their patented flu drugs and vaccines, had placed "insiders" within the WHO and other influential organizations. These individuals ultimately used their influence to lower the threshold for the WHO's definition of a "pandemic."
In 2009, the WHO revised its definition of a pandemic: as of June 2009, "a pandemic does not necessarily mean large numbers of infections or deaths." In other words, a virus that crosses borders and for which people have no immunity is now classified as a pandemic.
In June 2009, the WHO raised the A(H1N1) flu alert to the highest level, Phase 6, marking the first global flu pandemic declaration in 41 years.
**Investigating Key Figures Behind the Pandemic**
Following Wodarg's proposal, the Council of Europe earlier passed a resolution to investigate the role of pharmaceutical companies in the A(H1N1) flu outbreak.
Later in January, the Council of Europe will convene an emergency meeting to discuss the matter, after which strict investigations and hearings will be conducted into those responsible for declaring the public health emergency.According to Dutch media reports, Professor Osterhaus of Erasmus University in Rotterdam, nicknamed "Dr. Flu," is also a central figure in the global H1N1 flu panic.
The report states that Osterhaus is not only a key figure in the network referred to as the "pharmaceutical mafia" but also the chief advisor on pandemic flu for the World Health Organization. He has extremely close personal ties to the H1N1 vaccine production system and has profited from the billions of euros in vaccine sales.
The Dutch Senate has launched an investigation into Osterhaus, scrutinizing his serious breaches of public interest and misuse of funds.
Additionally, the UK’s *Daily Mail* previously exposed that Sir Anderson, who served as the British government’s advisor on the new flu, was employed by GlaxoSmithKline (GSK) with an annual salary of £116,000. The pharmaceutical company, which produces both antiviral drugs and flu vaccines, was one of the biggest beneficiaries of the H1N1 outbreak.
**2.6 deaths per 10,000 patients**
The mortality rate of the Spanish flu was 2 deaths per 100 patients, while the Asian flu and Hong Kong flu had 2 to 3 deaths per 1,000 patients. In contrast, the mortality rate of H1N1 flu was 2.6 deaths per 10,000 patients.
With a global population of 6 billion, previous flu outbreaks typically saw only 500 million people vaccinated. However, this time, the WHO estimated that around 3 billion vaccinations would be necessary, leading to an obvious surplus of vaccines.
Source: http://www. sinchew. com. my/ node/ 145681